Eli Lilly — Feb 4, 2026 release

The following table summarizes the company's full-year 2026 financial guidance: 2026 Guidance Revenue $80 to $83 billion Performance Margin (1)(2) 46.0% to 47.5% Tax Rate (2)(3) 18% to 19% Earnings per Share (2)(3)(4) $33.50 to $35.00 (1) The Company defines performance margin as gross margin less research and development and marketing, selling, and administrative expenses divided by revenue. (2) Excludes the impact of intangible asset amortization. (3) Guidance does not include acquired in-process research and development (IPR&D) either incurred or expected to be incurred, after December 31, 2025. (4) 2026 assumes shares outstanding of approximately 894 million 7 Webcast of Conference Call As previously announced, investors and the general public can access a live webcast of the Q4 2025 financial results conference call through a link on Lilly's website at investor.lilly.com/webcasts-and-presentations. The conference call will begin at 10 a.m. Eastern time today and will be available for replay via the website. Non-GAAP Financial Measures Certain financial information is presented on both a reported and a non-GAAP basis. Some numbers in this press release may not add due to rounding. Reported results were prepared in accordance with U.S. generally accepted accounting principles (GAAP) and include all revenue and expenses recognized during the periods. Historical non-GAAP measures reflect adjustments for the it